© Photo: Südkurier
QIAGEN Lake Constance – pocket-sized laboratories for the identification of pathogens
Quick, simple and decentralized – this is how QIAGEN Lake Constance GmbH envisages diagnostics applications in the future. The Stockach-based QIAGEN subsidiary develops test systems for point-of-need diagnostics, i.e. tests that can be carried out in close proximity to the sample collection point, for example in GP surgeries. They enable the rapid identification of pathogens, and as a result the timely initiation of suitable treatment.
Michael Schindler: HI virus and host interactions
Prof. Dr. Michael Schindler explores the interaction between viruses and their human host cells on the molecular level. His specific interest is HI virus infections and the mechanisms the virus uses to attack the human immune system. Schindler’s eventual aim is to identify a new target for the therapy of HIV infections. In April 2014, Schindler was appointed head of the Department of Molecular Virology of Human Infectious Diseases at the University Hospital in Tübingen.
First ever eye gene therapy close to clinical testing
There are many different retinal diseases simply because many different steps of the visual process can be affected. However, they all have one thing in common: correction of the relevant defective gene currently provides the only possibility of permanent cure. Prof. Dr. Mathias Seeliger and his group of researchers at the Institute of Ophthalmic Research at the University Hospital in Tübingen is specifically focused on the development of gene therapies for the treatment of neurodegenerative eye diseases. The techniques, developed in cooperation with colleagues from the University of Munich, have been lastingly successful in mice. A gene therapy for the treatment of this kind of retinal disease is now close to clinical testing.more
Crude mushroom solution to degrade micropollutants
Sabine Sané, a doctoral student in the Department of Microsystems Engineering (IMTEK) at the University of Freiburg, has developed a concept that shows how micropollutants can be degraded in wastewater and how the latter can serve as a valuable source of raw materials. She is one of four researchers who have been awarded the 2014 Huber Technology Prize “Future Water” with a purse of 10,000 euros. Her concept is based on an enzyme that is secreted by the turkey tail fungus Trametes versicolor. This enzyme, known as laccase, has been shown to efficiently degrade pollutants and increase the performance of biofuel cells.more